Oncology & Cancer

Merck KGaA suffers setback on cancer drug

German pharmaceuticals maker Merck KGaA said Thursday that phase III clinical trials of its gastric cancer drug Erbitux had shown no benefits for patients.

Genetics

2-D images as the new tool for cancer prevention

Portuguese researchers have developed a new method to analyze images of a protein in a population of cells to quantify its distribution for that population. The discovery by researchers João Sanches, Raquel Seruca and colleagues ...

Oncology & Cancer

Adjuvant radiochemotherapy has lasting benefit in gastric cancer

(HealthDay) -- Ten-year data from the Southwestern Oncology Group-directed Intergroup Study 0116 confirm the benefits of adjuvant radiochemotherapy after gastric cancer resection in terms of overall survival (OS) and relapse-free ...

page 15 from 26